Transactions

Paratek Pharmaceuticals, Inc.’s sale to Gurnet Point Capital and Novo Holdings A/S

Date Announced:
06/06/2023

client:
Paratek Pharmaceuticals, Inc.

Status:
Closed – 09/21/2023

Value:
$462 million